WallStreetZenWallStreetZen

NASDAQ: AKRO
Akero Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AKRO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$151.8M
Current Profit Margin
0%

AKRO Return on Equity

Current Company
-29.7%
Current Industry
-63.5%
Current Market
188%
AKRO's Return on Equity (-29.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AKRO announces earnings.

AKRO Return on Assets

Current Company
-27.2%
Current Industry
2.9%
AKRO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AKRO Return on Capital Employed

Current Company
-26.49%
Current Industry
19.5%
AKRO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AKRO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AKRO$0.00-$148.40M-$151.76MN/AN/A
ABCL$38.03M-$143.14M-$146.40M+33.91%N/A
MNKD$198.96M$20.62M-$11.94M+48.17%N/A
MIRM$186.37M-$135.87M-$163.42M+212.06%N/A
TARS$17.45M-$131.13M-$135.89M-44.69%N/A
View Top Biotech Stocks

AKRO earnings dates

Next earnings date
May 13, 2024

Akero Therapeutics Earnings & Revenue FAQ

What were AKRO's earnings last quarter?

On Invalid Date, Akero Therapeutics (NASDAQ: AKRO) reported Q4 2023 earnings per share (EPS) of -$1.02, up 142.86% year over year. Total Akero Therapeutics earnings for the quarter were -$55.19 million. In the same quarter last year, Akero Therapeutics's earnings per share (EPS) was -$0.42.

If you're new to stock investing, here's how to buy Akero Therapeutics stock.

What was AKRO's earnings growth in the past year?

As of Q2 2024, Akero Therapeutics's earnings has grown year over year. Akero Therapeutics's earnings in the past year totalled -$151.76 million.

What is AKRO's earnings date?

Akero Therapeutics's earnings date is Invalid Date. Add AKRO to your watchlist to be reminded of AKRO's next earnings announcement.

What was AKRO's revenue last quarter?

On Invalid Date, Akero Therapeutics (NASDAQ: AKRO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Akero Therapeutics's revenue was $0.00.

What was AKRO's revenue growth in the past year?

As of Q2 2024, Akero Therapeutics's revenue has grown null year over year. Akero Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.